Categories Earnings, Industrials
General Electric (GE) stock gains as Q4 profit tops estimates; revenues dip
Industrial conglomerate General Electric (NYSE: GE) reported a marked increase in fourth-quarter adjusted earnings, despite a modest decline in revenues. The results exceeded the market’s projection, sending the stock higher during Wednesday’s premarket session. The company also provided financial guidance for fiscal 2020.
For the fourth quarter, GE posted adjusted earnings of $0.21 per share, compared to $0.14 per share in the prior year. The bottom-line topped the Street view. On an unadjusted basis, the company reported earnings from continuing operations of $0.07 per share, compared to $0.06 per share last year.
Revenue Dips
Revenues declined 1% annually to $26.2 billion but exceeded experts’ target. However, the key business segments registered top-line growth. During the three-month period, total orders declined 5% year-over-year to $24.9 billion, with organic orders dropping 3%.
“We’re proud of our progress in 2019, including decisive actions to reduce our leverage and strengthen our businesses. Our work continues, but GE’s committed team, exceptional technology, and global network make me more confident than ever that we can deliver,” said CEO Lawrence Culp, Jr.
Outlook
Looking ahead, the management expects GE Industrial revenues to grow organically in the low-single-digit range in full-year 2020. In the Industrial segment, adjusted profit margin is expected to expand organically in a range from 0 to 75 basis points. Earnings, on an adjusted basis, are forecast to be in the range of $0.50 per share to $0.60 per share. The company is looking for free cash flow of $2-$4 billion for GE Industrial.
New CFO
GE also announced the appointment of Carolina Dybeck Happe as Chief Financial Officer, who will assume office early 2020. Kevin Cox has been appointed as Chief HR Officer and Pat Byrne as CEO of Digital.
Also read: General Electric Q3 2019 Earnings Call Transcript
GE shares gained 3% since the beginning of the year and 20% in the past twelve months. However, the stock underperformed the industry during that period.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on